Proliferative dysfunction in chronically activated T lymphocytes from chagasic patients (70.1)

dc.contributor.authorNicolás A. Giraldo
dc.contributor.authorNatalia I. Bolaños
dc.contributor.authorAdriana Cuéllar
dc.contributor.authorNubia Roa
dc.contributor.authorZulma M. Cucunubá
dc.contributor.authorVíctor Manuel Velasco
dc.contributor.authorFernando Rosas
dc.contributor.authorConcepción J. Puerta
dc.contributor.authorJohn Mario González
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T16:56:15Z
dc.date.available2026-03-22T16:56:15Z
dc.date.issued2012
dc.description.abstractAbstract Background: Trypanosoma cruzi persistence has been associated with cardiac and gastrointestinal tissue damage in nearly 30% of the infected individuals; however, the pathogenic mechanisms are yet unknown. This study’s goal was to compare the activation status and proliferative capacity of T lymphocytes among chronic chagasic patients and uninfected controls. Methodology: Twenty-seven chronic chagasic patients, 20 healthy individuals and 28 non-chagasic cardiomyopathy donors were analyzed. Peripheral blood cells were stained with CD3, CD4, CD8, CD28, HLA-DR and CD38. PBMCs were labeled with CFSE and co-cultivated with PHA or T. cruzi lysate; at the fifth day post-stimulation cells were stained for CD3, CD4 and CD8. Results: Chagasic patients displayed higher frequencies of CD4+ (P=0.0001) and CD8+ (P=0.0002) T cells co-expressing HLA-DR and CD38 in comparison with healthy and non-chagasic cardiomyopathy donors. Also, the former group exhibited lower percentages of CD8+/CD28+ T lymphocytes (P=0.0005). After 5 days of stimulation, the proliferation index was lower in both CD4+ (P=0.01) and CD8+ (P=0.04) PHA-stimulated T cells from chagasic donors when compared with both control groups. Conclusions: Despite their increased activation status, the T lymphocytes from chagasic donors displayed reduced proliferative capacity after mitogenic stimulation, corroborating a dysfunctional cellular immune response in the chronic stages of the disease.
dc.identifier.doi10.4049/jimmunol.188.supp.70.1
dc.identifier.urihttps://doi.org/10.4049/jimmunol.188.supp.70.1
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/61198
dc.language.isoen
dc.publisherAmerican Association of Immunologists
dc.relation.ispartofThe Journal of Immunology
dc.sourceUniversidad de Los Andes
dc.subjectCD38
dc.subjectCD28
dc.subjectCD8
dc.subjectChagas disease
dc.subjectCD3
dc.subjectImmunology
dc.subjectImmune system
dc.subjectPeripheral blood mononuclear cell
dc.subjectCardiomyopathy
dc.subjectStimulation
dc.titleProliferative dysfunction in chronically activated T lymphocytes from chagasic patients (70.1)
dc.typearticle

Files